Calling for rapid development of a safe and effective MERS vaccine

The geographic spread and rapid increase in the cases of Middle East respiratory syndrome (MERS) caused by a novel coronavirus (MERS-CoV) during the past two months have raised concern about its pandemic potential. Here we call for the rapid development of an effective and safe MERS vaccine to control the spread of MERS-CoV. (C) 2014 Published by Elsevier Masson SAS on behalf of Institut Pasteur.